Mỹ hoan nghênh thiện chí nối lại đối thoại của Triều Tiên

Ngày 12/9, Bộ Ngoại giao Mỹ lên tiếng hoan nghênh đề xuất của Triều Tiên về việc nối lại đối thoại phi hạt nhân hóa vào cuối tháng 9 này, song nêu rõ hiện hai bên vẫn chưa có kế hoạch gặp gỡ nào. Trước đó, Triều Tiên tuyên bố sẵn sàng đối thoại Mỹ vào cuối tháng 9, song Washington cần đưa ra một đề xuất mới mà phía Bình Nhưỡng có thể chấp nhận.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh